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Abstract
Dysregulated processing of natural rewards may be a central pathogenic process in the etiology 
and maintenance of prescription opioid misuse and addiction among chronic pain patients. This 
study examined whether a Mindfulness-Oriented Recovery Enhancement (MORE) intervention 
could enhance natural reward processing through training in savoring as indicated by event-related 
brain potentials (ERPs). Participants were chronic pain patients at risk for opioid misuse who were 
randomized to eight weeks of MORE (n=11) or a support group control condition (n=18). ERPs to 
images representing naturally rewarding stimuli (e.g., beautiful landscapes, intimate couples) and 
neutral images were measured before and after 8 weeks of treatment. Analyses focused on the late 
positive potential (LPP) - an ERP response in the 400 – 1000 ms time window thought to index 
allocation of attention to emotional information. Treatment with MORE was associated with 
significant increases in LPP response to natural reward stimuli relative to neutral stimuli which 
were correlated with enhanced positive affective cue-responses and reductions in opioid craving 
from pre- to post-treatment. Findings suggest that cognitive training regimens centered on 
strengthening attention to natural rewards may remediate reward processing deficits underpinning 
addictive behavior.
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Dysregulated processing of natural rewards is a key mechanism subserving the maintenance 
of drug addiction. Preclinical and clinical studies indicate that drug addiction results in 
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attenuated dopaminergic neurotransmission in response to natural rewards; this phenomenon 
has been observed among individuals with cocaine, methamphetamine, nicotine, alcohol, 
and opiate dependencies (Heinz et al. 2004; Kalivas and Volkow 2005; Lee et al. 2009; 
Lintas et al. 2012; Gipson et al. 2013). Substance dependent persons exhibit diminished 
subjective reward responsiveness and reduced brain activation to natural rewards compared 
to healthy control subjects (Volkow et al. 2010). Such reward processing deficits may have 
serious consequences for persons with substance use disorders. Indeed, reward valuation of 
salutary objects and events, encoded in dopaminergic activations of mesocorticolimbic brain 
circuits, is fundamental to flexible goal selection and the conservation of physical and 
psychological well-being. However, neurocognitive resources required for processing 
natural rewards may be hijacked by chronic exposure to psychoactive drugs, which, by 
eliciting changes to brain structure and function, reorganize basic learning mechanisms 
around pursuit of drug-induced reward and the alleviation of withdrawal-induced dysphoria 
and other aversive states (e.g., stress and pain) (Alcaro and Panksepp 2011). Putatively, this 
process is underpinned by allostatic changes to neural circuits subserving stress (e.g., 
amygdala) and reward (e.g., ventral striatum), through which the addict becomes 
increasingly insensitive to reward from healthful and socially affiliative stimuli, while 
becoming increasingly dependent on drug use to preserve hedonic homeostasis (Koob and 
Le Moal 2008).
Reward processing may be disrupted by illegal substances and prescription drugs alike. 
Indeed, emerging neuropsychopharmacologic models (Garland, Froeliger, Zeidan, Partin, & 
Howard, 2013) suggest that dyregulated reward processing is a central pathogenic process in 
the etiology of prescription opioid misuse and addiction among chronic pain patients. 
Chronic pain, coupled with opioid dose escalation, results in allostatic load on limbic-striatal 
neurocircuitry, resulting in decreased reward derived from healthful objects and events 
(Shurman, Koob, & Gutstein, 2010). The drive to alleviate dysphoria resulting from this 
reward deficit is manifested as craving, and may progress to the compulsive pattern of 
opioid use characteristic of opioid addiction (Koob & Le Moal, 2008). Evidence for 
dysregulation of natural reward processing in opioid addiction has been generated by studies 
showing reduced cue-elicited event-related brain potentials (ERPs) to images depicting 
natural rewards among opioid dependent individuals (Lubman et al. 2007, 2008) which 
predict future drug use (Lubman et al., 2009).
If dysregulated processing of natural rewards fuels the cycle of behavioral escalation from 
prescription opioid use to misuse and addiction, then enhancing natural reward processing 
may be a means of ameliorating or even reversing this pathogenic process. Plausibly, 
adaptive reward processing may be bolstered by therapeutic approaches which provide 
training in attending to and savoring naturally rewarding objects and events. Mindfulness 
training, which promotes emotion regulation through present-oriented attention (Holzel et 
al., 2011), may be especially efficacious in this regard. Though not the explicit goal of most 
mindfulness-based interventions, mindfulness may nonetheless amplify pleasure from 
perceptual and sensorimotor experiences in a fashion similar to sensate-focus techniques 
(Masters & Johnson, 1970) and promote positive emotion regulation by amplifying selective 
attentional processes (Wadlinger & Isaacowitz, 2010). We hypothesize that mindful 
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savoring increases attentional capacity to focus more intensely on both the pleasurable 
features of objects, persons, and events, as well as the positive emotions that arise from 
experiencing them.
Increased attention to sensory experience has been shown to elevate pleasure in eating and 
sex (Heiman & Meston, 1997; LeBel & Dubé, 2001), and attending to present-moment 
experience robustly predicts happiness in large-scale, time-lagged analyses (Killingsworth & 
Gilbert, 2010). More directly supportive of the “mindful savoring” hypothesis, mindful 
eating was found to increase ratings of subsequent food liking and enjoyment (Hong, 
Lishner, Han, & Huss, 2011; Hong, Lishner, & Han, 2014). Even stronger support may be 
derived from a randomized controlled trial (RCT) of Mindfulness-Based Cognitive Therapy 
(MBCT) with adults with residual depressive symptoms, which found that mindfulness 
training increased the experience of reward and positive emotion from pleasant daily life 
activities (Geschwind, Peeters, Drukker, van Os, &Wichers, 2011).
We recently conducted an early-stage RCT of Mindfulness-Oriented Recovery Enhancement 
(MORE) (Garland, Gaylord, Boettiger, & Howard, 2010; Garland, Manusov, Froeliger, 
Kelly, Williams, & Howard, 2014), a new multimodal intervention designed to address 
chronic pain, craving, and opioid misuse behaviors, which integrates training in savoring 
natural rewards with training in mindfulness and positive reappraisal techniques. Results of 
this RCT demonstrated that relative to a support group (SG) control condition, MORE 
significantly decreased pain severity and functional impairment, as well as opioid craving 
and opioid misuse (Garland et al., 2014). A subsequent analysis of data from a subset of 
individuals in this trial revealed that MORE led to enhanced cardiac-autonomic responses to 
natural reward cues which statistically mediated the effect of the intervention on reductions 
in opioid craving (Garland, Froeliger, & Howard, 2014). These findings are perhaps the first 
in the scientific literature to support the notion that a behavioral intervention can restore 
natural reward processing in addiction. Despite the compelling nature of the findings, 
autonomic psychophysiological indices measured in blocks of trials, as in the previous 
study, may not capture the time course of neural mechanisms involved in natural reward 
processing. Hence, in the present study, we examined a neurophysiological marker of 
reward processing using ERPs. ERPs, which have a temporal resolution on the order of 
milliseconds, can allow us to determine how MORE might impact both the temporal 
dynamics and magnitude of natural reward processing. In this investigation, we focused on 
an ERP waveform that has been linked to reward processing in studies of persons with 
substance use disorders and healthy controls: the late positive potential (LPP).
The LPP is a positive deflection of the EEG waveform that tends to reach maximum 
amplitude 400–800 ms at parietal sites (Pz) after onset of a motivationally salient stimulus. 
LPP amplitude is robustly correlated with subjective ratings of arousal in response to 
viewing emotional pictures (Cuthbert, Schupp, Bradley, Birbaumer, & Lang, 2000). Studies 
indicate that earlier time windows (< 1000 ms) of the LPP can be modulated by attentional 
manipulations (e.g., Olofsson, Nordin, Sequeira, & Polich, 2008), suggesting that this stage 
of the LPP indexes allocation of attention to emotional information. LPP activation is 
strongly correlated with activity in orbitofrontal and medial prefrontal cortex, amygdala, and 
insula as measured by fMRI (Liu, Huang, McGinnis-Deweese, Keil, & Ding, 2012; 
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Sabatinelli, Keil, Frank, & Lang, 2013). Of central importance to the current study, the LPP 
is also sensitive to top-down attentional control (Dunning & Hajcak, 2009; Scharmüller, 
Leutgeb, Schäfer, Köchel, & Schienle, 2011). In that regard, conscious down-regulation of 
negative emotional responses via reappraisal and reorienting of attention can reliably reduce 
the early and late time windows of the LPP (Hajcak & Nieuwenhuis, 2006; Moser, Hartwig, 
Moran, Jendrusina, & Kross, 2014; Schönfelder, Kanske, Heissler, & Wessa, 2013). 
Moreover, mindfulness training and related forms of meditation appear to reduce the LPP to 
negative affective stimuli (Gootjes, Franken, & Van Strien, 2011; Sobolewski, Holt, Kublik, 
& Wróbel, 2011). However, top-down enhancement of the LPP to positive emotional stimuli 
has proved to be an elusive target. Krompinger, Moser, and Simons (2008) found no effects 
on LPP magnitude when subjects were instructed to enhance positive emotions in response 
to pleasant photographs representing naturally rewarding stimuli.
If brain reward circuits instantiate a fundamental logic for goal selection (Shizgal and 
Hyman 2013), training in selective attention to natural rewards over drug rewards may 
reduce addictive propensities by shifting reward processing back to valuation of healthful 
and socially affiliative objects and behaviors. Hence, this study tested whether MORE could 
increase the LPP to natural reward cues in a sample of chronic pain patients at risk for 
prescription opioid misuse. We hypothesized that MORE would increase the parietal LPP to 
natural reward cues relative to neutral cues in the early time window where attention 
allocation predominates, and that this increase in LPP would be correlated with increased 
positive affective response to reward stimuli in individual difference analyses. Furthermore, 
given the clinical implications of the cardiac-autonomic findings in Garland, Froeliger, and 
Howard (2014), we hypothesized that increased LPP response to reward cues would be 
correlated with decreased opioid craving.
Method
Participants
This study examined data from a subset of participants (12 men and 17 women, mean age = 
47.1, SD = 15.2) in a previously published RCT of MORE vs. a support group (SG) for 
chronic pain and prescription opioid misuse (Garland et al., 2014). Individuals with 
complete pre-post treatment EEG data (MORE, n = 11; SG, n = 18) from a 
psychophysiological assessment conducted one week before, and one week after, the study 
treatments were selected for the present investigation. Participants were recruited from 
primary care, pain, and neurology clinics, and met study inclusion criteria if they reported 
recurrent pain on more days than not stemming from chronic non-cancer-related pain 
conditions (participants had been in chronic pain for an average of 12.7 years) and had taken 
opioid analgesics daily or nearly every day for at least the past 90 days (Chou et al., 2009). 
At each assessment point, participants completed self-report measures of opioid craving and 
then participated in a lab protocol which involved passively viewing visual images of 
naturally rewarding stimuli and neutral stimuli while EEG was recorded. The protocol was 
approved by the Florida State University IRB, and all procedures complied with standards 
set forth in the Helsinki Declaration of 1975. Participants were assessed for comorbid 
psychiatric disorders with the Mini-International Neuropsychiatric Interview 6.0 (MINI) 
Garland et al. Page 4













(Sheehan et al. 1998) and excluded if they were suicidal or psychotic. There were no 
significant pre-treatment between-groups differences in clinical characteristics (see Garland 
et al., 2014). Although all participants reported symptoms of physiological dependence (i.e., 
tolerance and withdrawal) on the MINI resulting from regular and prolonged opioid use , a 
smaller percentage (34.5%) met DSM-IV criteria for prescription opioid dependence (which 
includes psychological and behavioral as well as physiological signs and symptoms). 
However, most (86.2%) participants reported opioid analgesic misuse as defined by a 
validated cut-point on the Current Opioid Misuse Measure (COMM; Butler et al., 2007). 
Common comorbid psychiatric diagnoses included major depressive disorder (70.4%) and 
generalized anxiety disorder (33.3%); two participants also met criteria for post-traumatic 
stress disorder and alcohol abuse. Participants were paid $200 for the study. Following the 
pre-treatment assessment, participants were randomly assigned to an 8-week MORE group 
or SG.
MORE Group
The manualized 8-session MORE intervention (Garland, 2013) involved group training in 
mindfulness, reappraisal, and savoring skills designed to address mechanisms implicated in 
chronic pain and prescription opioid misuse. Group sessions were 2 hours long and led by a 
Masters-level social worker with over a decade of experience delivering mindfulness-based 
interventions to patients with psychiatric disorders. This clinician was supervised by the 
developer of MORE (the first author and an experienced, licensed psychotherapist). The first 
author reviewed video/audio-recordings of the sessions to monitor adherence to the MORE 
treatment manual and maintain treatment fidelity. MORE participants were asked to engage 
in daily 15 minute mindfulness practice sessions at home guided by a CD. Participants were 
instructed in savoring techniques which involved the use of mindfulness meditation to 
intentionally orient and sustain attention on the sensory features (i.e., visual, auditory, 
olfactory, gustatory, or tactile) of a pleasant experience or object (e.g., a beautiful nature 
scene like a sunset) while metacognitively reflecting on and absorbing any positive emotions 
arising in response to the pleasant event. For instance, participants were taught to mindfully 
focus their attention on the pleasant colors, textures, and scents of a bouquet of fresh flowers 
over a 20-minute long meditation session, and to attend to emotions of contentment and joy 
arising from this savoring practice. Comparable savoring techniques using an array of 
sensory targets were discussed across multiple sessions and prescribed as homework 
practice.
Support Group
The active control condition in this study consisted of 8 weekly, 2-hour support group 
sessions, in which a Master's-level clinical social worker facilitated emotional expression 
and discussion of topics pertinent to chronic pain and opioid use/misuse. This Rogerian, 
client-centered (Rogers, 2003) support group format was based on the evidence-based 
Matrix Model intensive outpatient treatment manual (Rawson & McCann, 2006). The first 
author reviewed video/audio-recordings of the sessions to monitor therapist adherence to the 
support group treatment manual and maintain treatment fidelity. Support group participants 
were asked to engage in 15 minutes of journaling a day on chronic pain-related themes at 
home.
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Procedures and Stimuli—Participants were first given a general description of the 
experiment, and then electroencephalogram/electro-oculogram (EEG/EOG) sensor 
electrodes were attached. Participants were seated approximately 0.5 m directly in front of a 
17-in computer monitor. Participants performed a randomized, event-related affective 
picture viewing task (Cuthbert et al., 2000) administered on computer, using Eprime 2.0 
software to control the presentation and timing of all stimuli. During the task, full-screen 
pictures from the International Affective Picture System (IAPS; Lang, Bradley, & Cuthbert, 
1997) were displayed in random order. Participants viewed 18 pleasant and 18 neutral IAPS 
pictures and were instructed to simply view the pictures as they were presented and allow 
themselves to respond naturally. A fixation cross (+) was presented for 500 ms at the 
beginning of each trial to orient participants to the center of the screen, and IAPS images 
were presented for 6 seconds following offset of the fixation cross. Responses were recorded 
for 6 seconds to measure effects on slower autonomic responses (not reported here), but in 
the present study, data from only the first second were analyzed to determine effects of 
MORE on LPP maxima. The inter-trial interval was randomly jittered from 2000 – 4000 ms. 
Following offset of the image, participants rated the valence of their affective response to 
the photograph (“How pleasant or unpleasant did you feel while viewing this photograph?”) 
on a 9-point scale ranging from “extremely unpleasant” to “extremely pleasant” and their 
degree of arousal (“How aroused or calm did you feel while viewing this photograph?”) 
from “extremely calm” to “extremely aroused.”
The natural reward picture set include images of endearing children and animals, athletic 
triumphs, appealing foods, beautiful landscapes, persons with happy facial expressions, and 
intimate/erotic couples. The neutral picture set included images of household items, 
furniture, and persons with neutral facial expressions. Natural reward and neutral images 
differed significantly on IAPS normative valence ratings (M = 7.09 and 5.05, respectively) 
and arousal ratings (M = 5.03 and 2.89, respectively).
ERPs—Continuous encephalographic (EEG) activity was recorded during the affective 
picture viewing paradigm described above using an ECI electrocap and a BIOPAC MP150 
system (BIOPAC, Goleta, CA). During the task, data was recorded from Pz, as well as Cz, 
Fz, F3, and F4 (although data from these sites are not reported in the present manuscript 
because our a prior hypotheses were focused on Pz --- see below), and reference electrodes 
were placed on the earlobes. Also using the BIOPAC, vertical and horizontal electro-
oculograms (EOG) recorded eye blinks and eye movements with miniature electrodes placed 
approximately 1 cm above and below the participant's right eye. All electrophysiological 
signals were digitized and analyzed on a computer with Acqknowledge 4.3 software 
(BIOPAC, Goleta, CA). The EEG was sampled at 1000 Hz, and signals were filtered online 
with a 35 Hz low pass filter. Off-line, the EEG for each trial was re-referenced to the mean 
of the ears, band-pass filtered between 0.01 and 30 Hz and artifact corrected for vertical and 
horizontal EOG movements using Gratton, Coles, and Donchin's (1983) classical approach. 
Trials were rejected for subsequent analyses if they were contaminated by excessive 
physiological artifacts. A semi-automated procedure identified and rejected physiological 
artifacts according to the following validated criteria: a voltage step > 50.0 μV between 
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sample points, a voltage difference of > 300.0 μV within a trial, and a maximum voltage 
difference < 0.50 μV within any 100-ms interval (Dunning & Hajcak, 2009; Hajcak, 
Dunning, & Foti, 2009). EEG signals were smoothed digitally off-line for visualization 
purposes but analyses were conducted on the pre-smoothed data.
For each participant, an average ERP waveform was generated separately for natural reward 
and neutral trials. To depict overall effects and identify the time window for establishing the 
largest LPP to be used in analyses of the effects of MORE on reward processing, grand 
average waveforms were generated by averaging individual participant waveforms across 
the MORE group (# of reward trials retained for analysis: M = 12.6±2.7; # of neutral trials: 
M = 12.8±2.9) and SG (# of reward trials retained for analysis: M = 12.4±2.7; # of neutral 
trials: M = 13.1±3.2). Statistical analyses for the LPP component (defined below) were 
conducted on averages from each participant. Given ample evidence in the literature that the 
LPP is maximized at parietal sites (e.g., Hajcak & Nieuwenhuis, 2006; Krompinger et al., 
2008; Olofsson et al., 2008), as well as after visually inspecting our own data for maximal 
LPP effects, we focused our LPP analyses on parietal site Pz. The LPP was quantified with 
the following procedure. First, a baseline equal to the average activity in the 150 ms window 
prior to image onset was subtracted from data points subsequent to image onset. Based on 
visual inspection and following conventions from previous research (Cuthbert et al., 2000), 
we defined the parietal LPP maxima as the average voltage in the time window from 400–
1000 ms. Because age and gender are known to significantly influence the LPP to affective 
picture viewing (cf., Olofsson et al., 2008), we controlled for these variables in all ERP 
analyses.
Opioid craving—A single item “How much do you want your opioids right now?” 
anchored on a 10-point scale (1 = not at all, 10 = extremely) assessed current opioid craving 
once during the assessment session in the week prior to intervention and once during the 
assessment session in the week following intervention. Opioid craving scores as measured 
by this item have been significantly positively correlated with scores on the COMM, a 
validated measure of opioid misuse (Garland et al., 2014). Similar single-item measures of 
craving have been validated and shown to distinguish high- from low-risk opioid-using 
chronic pain patients and predict opioid misuse (Wasan et al., 2009).
Results
Pre-treatment LPP Response
Figure 1 presents the ERP waveforms associated with natural reward and neutral stimuli 
during passive viewing. In this sample, there was a small positive deflection in the EEG 
consistent with the LPP which began approximately 400 ms after stimulus onset and 
continued for several hundred ms. To determine if natural reward cues elicited a 
significantly greater LPP than neutral cues prior to treatment, a one-way (Cue Type: Natural 
Reward vs. Neutral) ANOVA was conducted, F(1,25) = 2.04, p = .16, indicating that, on 
average, natural reward cues did not elicit significantly greater LPP activation than neutral 
cues. There were also no significant between-groups differences in pre-treatment LPP 
activation to natural reward or neutral cues.
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Effects of Treatment on LPP to Natural Reward Cues
Figure 2a and 2b depict changes in LPP response to reward cues from pre- to post-treatment 
in the MORE group and SG, respectively. Following convention (Cuthbert et al., 2000; 
Moser et al., 2009; 2014), and because visual inspection of our data indicated that the 
parietal LPP began around 400 ms and ended around 1000 ms, effects of treatment on the 
LPP were examined from 400 – 1000 ms with repeated measures ANOVA. Emerging from 
this analysis was a significant Treatment Group (MORE vs. SG) × Time (Pre-Post 
Treatment) × Cue Type (Natural Reward vs. Neutral) interaction, F(1,25) = 4.99, p = .035, 
ηpartial
2 = .17. Compared to the SG, the MORE group evidenced pre-post treatment 
increases in LPP activation to natural reward cues across the 400 – 1000 ms window, 
indicating that MORE enhanced electrocortical indices of reward processing. The Treatment 
Group × Time × Cue Type interaction remained significant in a sensitivity analysis 
controlling for pre-treatment opioid dependence status, F(1,24) = 4.80, p = .038, ηpartial2 = .
17.
Individual Differences in Psychological Correlates of Treatment-Related Change in Natural 
Reward Processing
Linear regression analyses were used to examine individual differences in psychological 
correlates of natural reward cue-specific changes in LPP response over time. For these 
analyses, we created difference scores subtracting LPP activation to neutral cues from LPP 
activation to natural reward cues. These scores represent LPP activation that is specific to 
natural reward processing. In light of the phenotypic variability in the sample, we used 
regression models to assess increased LPP reward response as a predictor of residualized 
change in affect and craving, covarying pre-treatment levels of these psychological variables 
as well as pre-treatment opioid dependence status to control for subject heterogeneity.
We found that pre-post treatment increases in LPP activation during natural reward 
processing predicted residualized change in affective response elicited by natural reward 
cues (β = .66, p < .001, model R2 = .52). Individuals who exhibited greater LPP responses to 
natural reward cues reported greater increases in pleasant (positive) affect in response to 
those cues from pre- to post-treatment. In contrast, pre-post treatment increases in LPP 
activation did not significantly predict residualized change in subjective arousal response 
elicited by natural reward cues (p > .10).
In an additional regression model, we found that pre-post treatment increases in LPP 
activation during natural reward processing predicted residualized change in self-reported 
opioid craving (β = -.42, p = .03, model R2 = .29). Individuals who exhibited greater LPP 
responses to natural reward cues reported greater decreases in opioid craving from pre- to 
post-treatment.
Discussion
The present study provides direct neurophysiological evidence in support of the hypothesis 
that MORE modulates natural reward processing in opioid (mis)using chronic pain patients 
by enhancing the LPP at the stage of attentional allocation. After completing 8 weeks of 
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treatment and in comparison to the SG, participants in the MORE group exhibited a 
heightened LPP response to natural reward stimuli relative to neutral stimuli. In individual 
difference analyses, increases in electrocortical activity during reward processing predicted 
enhanced positive affective responses to the photographs and reductions in opioid craving 
from pre- to post-treatment.
Study findings have implications for clinical and basic science. From a clinical standpoint, 
enhancement of natural reward processing in a sample of chronic pain patients at risk for 
opioid misuse by a multimodal, mindfulness-oriented intervention suggests that allostatic 
processes in addiction might be countered by cognitive training regimens centered on 
strengthening selective attention to natural rewards. MORE provides training in mindful 
savoring techniques, which involve intentional deployment and maintenance of attention on 
the pleasant features of healthful and socially affiliative objects and events, coupled with 
cultivation of reflexive awareness of positive emotional states without clinging. This latter 
point is of critical importance, given the impermanent nature of positive emotions and the 
ubiquity of pain, suffering, and stressful events in life (and particularly so in the patient 
population under investigation in the present study). MORE does not promote attachment to 
positive experience, but rather aims to foster a deep appreciation of moment-by-moment 
positive experience no matter how fleeting. Further, in the MORE treatment approach, 
mindful savoring techniques are tempered by other mindfulness techniques designed to 
promote attention to and acceptance of pain, craving, and negative emotions (Garland, 
2013). Through such an approach, it is plausible that learning to mindfully attend to and 
savor positive events may offset the negative affect and anhedonia characteristic of persons 
suffering from chronic pain and opioid use disorders.
From a basic affective neuroscience perspective, current study findings suggest that repeated 
practice of conscious, top-down modulation of attentional allocation onto the positive 
features of a stimulus context can in fact amplify ERPs during motivated attention to natural 
reward stimuli. That these effects were observed for the LPP when it reached its maximum 
amplitude between 400 – 1000 ms suggests that mindful savoring may be an “antecedent” 
emotion regulation strategy (Gross, 1998) that can “boost the gain” on downstream 
emotional experience. In that regard, individuals who experienced the largest increases in 
LPP from pre- to post-treatment also reported the greatest increases in positive affective 
response during picture viewing. Hypothetically, this process may involve strengthening 
functional connectivity between a predominately left-lateralized metacognitive attentional 
control network (comprised of dorsolateral PFC, dorsal anterior cingulate cortex, and 
parietal cortex), the amgydala and insula, and the striatum, which, when operating in 
concert, may remediate impaired dopaminergic responses to hedonic stimuli and help to 
regulate craving (Garland, Froeliger, & Howard, 2014). This speculation is consistent with 
neuroimaging data indicating that volitional up-regulation of positive emotion is subserved 
by increased activation in PFC, caudate, and putamen (Kim & Hamann, 2007), and studies 
demonstrating that a prefrontal-striatal pathway is involved in the regulation of substance 
craving (Kober et al., 2011). Several prior reports suggest that meditation practice can 
enhance dopaminergic tone (Hagerty et al., 2013; Kjaer et al., 2002) and increase left-
lateralized activation in prefrontal cortex (Davidson et al., 2003).
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That said, LPP responses during the affective picture viewing task are at best indirect 
proxies of potential neural correlates of clinical outcome. Thus, it is unknown whether the 
observed modulations in LPP responses reflect changes in therapeutic mechanism or 
outcomes. To probe this question, future neuroimaging studies are needed to assess the 
neural correlates of outcome, including possible changes in underlying reward circuitry 
(e.g., corticostriatal) function. For example, resting-state functional connectivity analyses 
would allow for investigation of MORE's effects on the strength of basal reward circuitry 
function, whereas explicit emotion regulation paradigms would enable examination of 
MORE's effects on restoration of proactive, prefrontally mediated control over reward 
processes.
As a plausible alternative interpretation of the current study findings, it is possible that the 
observed modulations of LPP function were due to reductions in opioid intake over the 
course of the study. Reduction in opioid intake might improve dopaminergic pathway 
functioning, in light of the known effects of opioids on dopamine signaling in the nucleus 
accumbens (for a review, see Garland et al., 2013). However, we were unable to test this 
hypothesis due to the lack of a quantitative measure of opioid dosing. Although we 
attempted to administer a self-report measure of daily opioid dosing, we were unable to 
obtain accurate opioid dosing data for the entire sample due to non-responses and 
ambiguous responses (e.g., reporting the opioid dose without reporting number of pills taken 
per day). Consequently, we do not know to what extent MORE increased reward processing 
by reducing opioid use, or vice versa.
This study was limited in several other respects. First, MORE is a multimodal intervention 
that integrates mindfulness training with reappraisal and savoring techniques, and it is 
possible that any of these techniques separately, or in synergy, might enhance reward 
processing. Thus, we cannot disentangle the unique contribution that each of these 
techniques may have had on LPP response to natural reward cues. Future studies could 
employ dismantling designs and/or instruct participants to actively up-regulate positive 
emotion while viewing positive affective stimuli to parse the effects of mindful savoring 
from other intervention components. Further, the sample was small and heterogeneous, 
comprised of opioid misusers and those who met full DSM criteria for opioid dependence; 
the distinct nature of these phenotypes may have contributed to the degree of variability in 
the present study findings. Also, our LPP results might have been attenuated because the 
athletic photos from the IAPS we used tend to elicit weaker LPPs (Weinberg & Hajcak, 
2010). To overcome these limitations, future studies should employ larger, more 
homogenous samples, as well as evaluate opioid dosing usage via a multi-pronged approach 
including toxicology screens, prescription history, pill count, and self-report.
Although the findings should be considered preliminary and heuristically informative given 
the limitations outlined above, the present exploratory study suggests that MORE may 
remediate deficits in natural reward processing among chronic pain patients at risk for 
opioid misuse by enhancing the allocation of attention to salutary objects and events. 
Restoration of the ability to extract a sense of reward, fulfillment, and meaning out of 
everyday pleasures may be crucial to the ability to self-generate positive emotions and to 
resilience itself (Garland et al., 2010). Research demonstrates that pleasant events actually 
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outnumber unpleasant events by a 3-to-1 margin in everyday life (Oishi, Diener, Choi, Kim-
Prieto, & Choi, 2007). Thus, naturally rewarding experiences are abundant, if people notice 
and appreciate them. Teaching clients to mindfully attend to positive aspects of their life 
experience (e.g., the sight of a beautiful sunset, the touch of a cherished loved one, or the 
taste of a nourishing meal) may increase the perceived value of natural rewards, and thereby 
counter the insensitivity to pleasurable objects, events, and experiences that can result from 
chronic pain and addiction. Future behavioral medicine research using neurophysiological 
measures may reveal that focusing one's attentional lens to more richly process the 
pleasurable, interesting, and meaningful experiences in life may make the painful and 
dissatisfying ones insignificant by comparison.
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Grand average picture-locked event-related potentials at site Pz during viewing of natural 
reward and neutral cues by chronic pain patients (N = 29) prior to participation in study 
treatments. The y-axis is in microvolts; the x-axis is time in milliseconds.
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Figure 2a & 2b. Pre-post treatment changes in LPP (400 – 1000 ms) response at Pz during 
viewing of natural reward cues for A) Mindfulness-Oriented Recovery Enhancement 
(MORE) participants (n = 11) and B) Support Group (SG) participants (n = 18). The y-axis 
is in microvolts; the x-axis is time in milliseconds.
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Difference waves at Pz (mean activation to natural reward cues – mean activation to neutral 
cues) for the Mindfulness-Oriented Recovery Enhancement (MORE, n = 11) and Support 
Groups (SG, n = 18). The y-axis is in microvolts; the x-axis is time in milliseconds.
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